{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:15:11Z","timestamp":1782587711557,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108014"],"award-info":[{"award-number":["81820108014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071407"],"award-info":[{"award-number":["82071407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771361"],"award-info":[{"award-number":["81771361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901277"],"award-info":[{"award-number":["81901277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long non-coding RNAs (lncRNAs), functioning as competing endogenous RNAs (ceRNAs), have been reported to play important roles in the pathogenesis of autoimmune diseases. However, little is known about the regulatory roles of lncRNAs underlying the mechanism of myasthenia gravis (MG). The aim of the present study was to explore the roles of lncRNAs as ceRNAs associated with the progression of MG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>MG risk genes and miRNAs were obtained from public databases. Protein\u2013protein interaction (PPI) network analysis and module analysis were performed. A lncRNA-mediated module-associated ceRNA (LMMAC) network, which integrated risk genes in modules, risk miRNAs and predicted lncRNAs, was constructed to systematically explore the regulatory roles of lncRNAs in MG. Through performing random walk with restart on the network, HCG18\/miR-145-5p\/CD28 ceRNA axis was found to play important roles in MG, potentially. The expression of HCG18 in MG patients was detected using RT-PCR. The effects of HCG18 knockdown on cell proliferation and apoptosis were determined by CCK-8 assay and flow cytometry. The interactions among HCG18, miR-145-5p and CD28 were explored by luciferase assay, RT-PCR and western blot assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Based on PPI network, we identified 9 modules. Functional enrichment analyses revealed these modules were enriched in immune-related signaling pathways. We then constructed LMMAC network, containing 25 genes, 50 miRNAs, and 64 lncRNAs. Through bioinformatics algorithm, we found lncRNA HCG18 as a ceRNA, might play important roles in MG. Further experiments indicated that HCG18 was overexpressed in MG patients and was a target of miR-145-5p. Functional assays illustrated that HCG18 suppressed Jurkat cell apoptosis and promoted cell proliferation. Mechanistically, knockdown of HCG18 inhibited the CD28 mRNA and protein expression levels in Jurkat cells, while miR-145-5p inhibitor blocked the reduction of CD28 expression induced by HCG18 suppression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We have reported a novel HCG18\/miR-145-5p\/CD28 ceRNA axis in MG. Our findings will contribute to a deeper understanding of the molecular mechanism of and provide a novel potential therapeutic target for MG.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-021-03138-0","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:03:20Z","timestamp":1637233400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses"],"prefix":"10.1186","volume":"19","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrui","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2782-4010","authenticated-orcid":false,"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3389\/fimmu.2017.01785","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Yan Y. Immunopathogenesis in myasthenia gravis and neuromyelitis optica. Front Immunol. 2017;8:1785.","journal-title":"Front Immunol"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","volume":"52","author":"P Zisimopoulou","year":"2014","unstructured":"Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, et al. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun. 2014;52:139\u201345.","journal-title":"J Autoimmun"},{"issue":"12","key":"3138_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1212\/WNL.0000000000000804","volume":"83","author":"JH Yeh","year":"2014","unstructured":"Yeh JH, Chen HJ, Chen YK, Chiu HC, Kao CH. Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study. Neurology. 2014;83(12):1075\u20139.","journal-title":"Neurology"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"674786","DOI":"10.3389\/fchem.2021.674786","volume":"9","author":"A Eftekhari","year":"2021","unstructured":"Eftekhari A, Arjmand A, Asheghvatan A, \u0160vajdlenkov\u00e1 H, \u0160au\u0161a O, Abiyev H, et al. The potential application of magnetic nanoparticles for liver fibrosis theranostics. Front Chem. 2021;9:674786.","journal-title":"Front Chem"},{"issue":"11","key":"3138_CR5","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/ma14112939","volume":"14","author":"A Eftekhari","year":"2021","unstructured":"Eftekhari A, Maleki Dizaj S, Ahmadian E, Przekora A, Hosseiniyan Khatibi SM, Ardalan M, et al. Application of advanced nanomaterials for kidney failure treatment and regeneration. Materials. 2021;14(11):2939.","journal-title":"Materials"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jocn.2019.08.079","volume":"69","author":"GM Cai","year":"2019","unstructured":"Cai GM, Gao Z, Yue YX, Xie YC, Gao X, Hao HJ, et al. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort. J Clin Neurosci. 2019;69:31\u20137.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"3138_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1109\/TCBB.2015.2396073","volume":"12","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhao H, Ng MK. Functional module analysis for gene coexpression networks with network integration. IEEE\/ACM Trans Comput Biol Bioinform. 2015;12(5):1146\u201360.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"13","key":"3138_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491\u2013509.","journal-title":"Cell Mol Life Sci"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-03103-8_1","volume":"50","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol. 2010;50:1\u201320.","journal-title":"Prog Mol Subcell Biol"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2017.08.008","volume":"183","author":"M Luo","year":"2017","unstructured":"Luo M, Liu X, Meng H, Xu L, Li Y, Li Z, et al. IFNA-AS1 regulates CD4(+) T cell activation in myasthenia gravis though HLA-DRB1. Clin Immunol. 2017;183:121\u201331.","journal-title":"Clin Immunol"},{"key":"3138_CR11","doi-asserted-by":"publisher","unstructured":"Liu X, Luo M, Meng H, Zeng Q, Xu L, Hu B, et al. MiR-181a regulates CD4(+) T cell activation and differentiation by targeting IL-2 in the pathogenesis of myasthenia gravis. Eur J Immunol. 2019. https:\/\/doi.org\/10.1002\/eji.201848007.","DOI":"10.1002\/eji.201848007"},{"issue":"1","key":"3138_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000494802","volume":"26","author":"YL Cao","year":"2019","unstructured":"Cao YL, Dong W, Li YZ, Han W. MicroRNA-653 inhibits thymocyte proliferation and induces thymocyte apoptosis in mice with autoimmune myasthenia gravis by downregulating TRIM9. NeuroImmunoModulation. 2019;26(1):7\u201318.","journal-title":"NeuroImmunoModulation"},{"issue":"3","key":"3138_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"1","key":"3138_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12943-018-0874-1","volume":"17","author":"XZ Yang","year":"2018","unstructured":"Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt\/beta-catenin pathway. Mol Cancer. 2018;17(1):126.","journal-title":"Mol Cancer"},{"issue":"2","key":"3138_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","volume":"15","author":"MC Dalakas","year":"2019","unstructured":"Dalakas MC. Immunotherapy in myasthenia gravis in the era of biologics. Nat Rev Neurol. 2019;15(2):113\u201324.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"3138_CR16","doi-asserted-by":"publisher","first-page":"e0214857","DOI":"10.1371\/journal.pone.0214857","volume":"14","author":"S Li","year":"2019","unstructured":"Li S, Cao Y, Li L, Zhang H, Lu X, Bo C, et al. Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis. PLoS ONE. 2019;14(4):e0214857.","journal-title":"PLoS ONE"},{"issue":"8","key":"3138_CR17","doi-asserted-by":"publisher","first-page":"e104827","DOI":"10.1371\/journal.pone.0104827","volume":"9","author":"L Yang","year":"2014","unstructured":"Yang L, Wang J, Sun X, Cao Y, Ning S, Zhang H, et al. Identifying a polymorphic \u201cswitch\u201d that influences miRNAs\u2019 regulation of a myasthenia gravis risk pathway. PLoS ONE. 2014;9(8):e104827.","journal-title":"PLoS ONE"},{"issue":"D1","key":"3138_CR18","doi-asserted-by":"publisher","first-page":"D902","DOI":"10.1093\/nar\/gkw1038","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Cao Y, Zhang H, Wang T, Tian Q, Lu X, et al. NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases. Nucleic Acids Res. 2017;45(D1):D902\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3138_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"3138_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2.","journal-title":"BMC Bioinform"},{"issue":"5","key":"3138_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"D1","key":"3138_CR22","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48(D1):D148\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"3138_CR23","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3138_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"Consortium GT","year":"2013","unstructured":"Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","journal-title":"Nat Genet"},{"key":"3138_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fbioe.2020.00138","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Gao Y, Wang P, Zhi H, Zhang Y, Guo M, et al. CLING: candidate cancer-related lncRNA prioritization via integrating multiple biological networks. Front Bioeng Biotechnol. 2020;8:138.","journal-title":"Front Bioeng Biotechnol"},{"key":"3138_CR26","doi-asserted-by":"publisher","first-page":"511676","DOI":"10.3389\/fgene.2020.511676","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Zheng S, Li X, Ding Y, Zhang M, Lin L, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network identified lncRNA EPB41L4A-AS1 as a potential biomarker in non-small cell lung cancer. Front Genet. 2020;11:511676.","journal-title":"Front Genet"},{"issue":"1","key":"3138_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"AR Jaretzki","year":"2000","unstructured":"Jaretzki AR, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55(1):16\u201323.","journal-title":"Neurology"},{"key":"3138_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.omtn.2020.01.005","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, Cao Y, Lu X, Wang X, Kong X, Bo C, et al. Identification of the regulatory role of lncRNA SNHG16 in myasthenia gravis by constructing a competing endogenous RNA network. Mol Ther Nucleic Acids. 2020;19:1123\u201333.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"3138_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s11481-013-9498-9","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Zheng S, Xin N, Dou C, Fu L, Zhang X, et al. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response. J Neuroimmune Pharmacol. 2013;8(5):1287\u2013302.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"3138_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0165-5728(00)00191-0","volume":"105","author":"D Huang","year":"2000","unstructured":"Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol. 2000;105(1):69\u201377.","journal-title":"J Neuroimmunol"},{"key":"3138_CR31","doi-asserted-by":"publisher","first-page":"153303382199006","DOI":"10.1177\/1533033821990064","volume":"20","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen Z, Mo J, Pang M, Chen Z, Feng F, et al. Identification of HCG18 and MCM3AP-AS1 that associate with bone metastasis, poor prognosis and increased abundance of M2 macrophage infiltration in prostate cancer. Technol Cancer Res Treat. 2021;20:1533033821990064.","journal-title":"Technol Cancer Res Treat"},{"key":"3138_CR32","first-page":"111","volume":"4","author":"N Beyersdorf","year":"2015","unstructured":"Beyersdorf N, Kerkau T, Hunig T. CD28 co-stimulation in T-cell homeostasis: a recent perspective. Immunotargets Ther. 2015;4:111\u201322.","journal-title":"Immunotargets Ther"},{"issue":"3","key":"3138_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","volume":"33","author":"Z Cheng","year":"2013","unstructured":"Cheng Z, Qiu S, Jiang L, Zhang A, Bao W, Liu P, et al. MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1. J Clin Immunol. 2013;33(3):567\u201376.","journal-title":"J Clin Immunol"},{"issue":"11","key":"3138_CR34","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Investig. 2006;116(11):2843\u201354.","journal-title":"J Clin Investig"},{"issue":"7","key":"3138_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/biom10071044","volume":"10","author":"V Lodde","year":"2020","unstructured":"Lodde V, Murgia G, Simula ER, Steri M, Floris M, Idda ML. Long noncoding RNAs and circular RNAs in autoimmune diseases. Biomolecules. 2020;10(7):1044.","journal-title":"Biomolecules"},{"issue":"11","key":"3138_CR36","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1111\/cas.14634","volume":"111","author":"K Zhang","year":"2020","unstructured":"Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, et al. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci. 2020;111(11):4041\u201350.","journal-title":"Cancer Sci"},{"key":"3138_CR37","doi-asserted-by":"publisher","first-page":"694571","DOI":"10.3389\/fgene.2021.694571","volume":"12","author":"W Sheng","year":"2021","unstructured":"Sheng W, Guo W, Lu F, Liu H, Xia R, Dong F. Upregulation of Linc00284 promotes lung cancer progression by regulating the miR-205-3pc-Met axis. Front Genet. 2021;12:694571.","journal-title":"Front Genet"},{"issue":"5","key":"3138_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jb\/mvaa073","volume":"168","author":"Y Zou","year":"2020","unstructured":"Zou Y, Sun Z, Sun S. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p\/CENPM axis. J Biochem. 2020;168(5):535\u201346.","journal-title":"J Biochem"},{"issue":"23","key":"3138_CR39","first-page":"10387","volume":"23","author":"L Li","year":"2019","unstructured":"Li L, Ma TT, Ma YH, Jiang YF. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140CCND1 and Hedgehog signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(23):10387\u201399.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3138_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11010-020-03923-3","volume":"476","author":"W Ren","year":"2021","unstructured":"Ren W, Xi G, Li X, Zhao L, Yang K, Fan X, et al. Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-146a\/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy. Mol Cell Biochem. 2021;476(1):471\u201382.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"3138_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3892\/ijmm.2017.2853","volume":"39","author":"Y Cao","year":"2017","unstructured":"Cao Y, Lu X, Wang J, Zhang H, Liu Z, Xu S, et al. Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis. Int J Mol Med. 2017;39(2):268\u201378.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3138_CR42","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41598-021-81962-6","volume":"11","author":"C Bo","year":"2021","unstructured":"Bo C, Zhang H, Cao Y, Lu X, Zhang C, Li S, et al. Construction of a TF-miRNA-gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis. Sci Rep. 2021;11(1):2416.","journal-title":"Sci Rep"},{"issue":"1","key":"3138_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jfda.2018.12.002","volume":"27","author":"X He","year":"2019","unstructured":"He X, Deng H, Hwang HM. The current application of nanotechnology in food and agriculture. J Food Drug Anal. 2019;27(1):1\u201321.","journal-title":"J Food Drug Anal"},{"key":"3138_CR44","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.biopha.2018.04.126","volume":"103","author":"A Eftekhari","year":"2018","unstructured":"Eftekhari A, Dizaj SM, Chodari L, Sunar S, Hasanzadeh A, Ahmadian E, et al. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities. Biomed Pharmacother. 2018;103:1018\u201327.","journal-title":"Biomed Pharmacother"},{"key":"3138_CR45","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3389\/fonc.2020.01734","volume":"10","author":"WJ Yu","year":"2020","unstructured":"Yu WJ, Huang DX, Liu S, Sha YL, Gao FH, Liu H. Polymeric nanoscale drug carriers mediate the delivery of methotrexate for developing therapeutic interventions against cancer and rheumatoid arthritis. Front Oncol. 2020;10:1734.","journal-title":"Front Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-03138-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-021-03138-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-03138-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:29:24Z","timestamp":1720704564000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-021-03138-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1186\/s12967-021-03138-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}